Hormetic and UV-protective effects of azulene-related compounds

In Vivo

Volumn 25, Issue 1, 2011, Pages 41-48

  Ueki, Jun Ichi ^a   Shimada, Aki ^a   Sakagami, Hiroshi ^b   Wakabayashi, Hidetsugu ^a  

^a JOSAI UNIVERSITY   (Japan)

^b MEIKAI UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

Author keywords

Azulenes; Hormesis; UV protection

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 3 ETHYL 1 TRICHLOROACETYLAZULENE; 3 METHYL 1 TRICHLOROACETYLAZULENE; 6,8 DIBROMOBENZO[B]CYCLOHEPTA[E][1,4]THIAZINE; ASCORBIC ACID; AZULENE; BENZO[B]CYCLOHEPTA[E][1,4]OXAZIN 6 (11 H) ONE; BENZO[B]CYCLOHEPTA[E][1,4]THIAZINE; CASPASE 3; NITRIC OXIDE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BIOLOGICAL ACTIVITY; CANCER CELL CULTURE; CELL DAMAGE; CELL GROWTH; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG POTENTIATION; FIBROBLAST; GINGIVA; HORMESIS; HUMAN; HUMAN CELL; MACROPHAGE ACTIVATION; PERIODONTAL LIGAMENT; RADIATION PROTECTION; SQUAMOUS CELL CARCINOMA; TOOTH PULP;

EID: 79952033200     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Heterocyclic Chemistry, Bioactive Heterocycles VI. Motohashi N (ed.). Flavonoids and Anthocyanins in Plants and Latest Bioactive N-Heterocycles. Germany, Springer, 2008.
2. Nozoe T and Asao T: Azulenes and heptafulvenes. In: Dai-Yuki Kagaku. Kotake M (ed.), Tokyo, Asakura-Shoten, Vol. 13, pp. 439-534, 1960 (in Japanese).
3. Nozoe T, Breslow R, Hafner K, Ito S and Murata I: Topics in Nonbenzenoid Aromatic Chemistry. Tokyo, Hirokawa Publ. Co., Vol I: pp. 1-295, 1973.
4. Nozoe T, Breslow R, Hafner K, Ito S and Murata I: Topics in Nonbenzenoid Aromatic Chemistry. Tokyo, Hirokawa Publ. Co., Vol II: pp. 1-379, 1977.
5. Zeller KP: Methoden der organischen chemie. New York, Houben-Weyl, Band V/2c, pp. 127-418, 1985.
6. Ziegler K and Hafner K: Eine rationelle synthese des azulens. Angew Chem 67: 301, 1955.
7. Hafner K: Zur kenntnis der azulene I. Eine neue azulen-synthese. Justus Liebigs Ann Chem 606: 79-87, 1957.
8. Hafner K: Uber substituierte azulene. Angew Chem 69: 393, 1957.
9. Frigola J, Pares J, Corbera J, Vano D, Merce R, Torrens A, Mas J and Valenti E: 7-Azetidinylquinolones as antibacterial agents. Synthesis and structure-activity relationship. J Med Chem 36: 801-810, 1993. (Pubitemid 23118771)
10. Wakabayashi S, Sekiguchi H, Kosakai K, Mochizuki S, Kashima M and Tomiyama A: General pharmacological properties of an anti-ulcer drug, azuletil sodium (KT1-21). Folia Pharmacol Japon 96: 185-204, 1990 (in Japanese). (Pubitemid 20343815)
11. 2-(2-pyridylmethyl)-5-isopropyl- 3,8-dimethylazulene-1-carboxamidine (HNS-32) in pig coronary artery. Pharm Pharmacol Commun 6: 397-404, 2002.
12. Tomiyama T, Yokota M, Wakabayashi S, Kosakai K and Yanagisawa T: Design, synthesis, and pharmacology of 3-substituted sodium azulene-1-sulfonates and related compounds: non-prostanoid thromboxane A2 receptor antagonists. J Med Chem 36: 791-800, 1993.
13. Doukas PH, Speaker TJ and Thompson RS: Azulene analogs of pharmacological agents. III. Acute toxicity and local anesthetic activity of azulylamides and azulenecarboxamides. J Pharm Sci 64: 158-161, 1975.
14. Hamajima R, Fujimoto T and Okuda H: Studies on azulene derivatives (II). Absorption, distribution, metabolism and excretion of sodium guaiazulene-3-sulfonate. Appl Pharmacol 12: 501-510, 1976 (in Japanese).
15. Fujimoto T, Yoshimura A, Nishimura H and Okuda H: Studies on azulene derivatives (III). Pharmacokinetic studies of sodium guaiazulene-3-sulfonate (35S-GAS) through the rat mucosa. Appl Pharmacol 12: 511-520, 1976 (in Japanese).
16. Akatsu Y, Ohshima N, Yamagishi Y, Nishishiro M, Wakabayashi H, Kurihara T, Kikuchi H, Katayama T, Motohashi N, Shoji Y, Nakashima H and Sakagami H: Apoptosis-inducing activity of trihaloacetylazulenes against human oral tumor cell lines. Anticancer Res 26: 1917-1924, 2006.
17. Murayama H, Miyahara K, Wakabayashi H, Kurihara T, Hashimoto K, Amano O, Kikuchi H, Nakamura Y, Kanda Y, Kunii S, Motohashi N and Sakagami H: Tumor-specific cytotoxicity and type of cell death induced by benzocycloheptoxazines in human tumor cell lines. Anticancer Res 28: 1069-1078, 2008. (Pubitemid 351578956)
18. Narita T, Suga A, Kobayashi M, Hashimoto K, Sakagami H, Motohashi N, Kurihara T and Wakabayashi H: Tumor-specific cytotoxicity and type of cell death induced by benzo[b]cyclohept [e][1,4]oxazine and 2-aminotropone derivatives. Anticancer Res 29: 1123-1130, 2009.
19. Miyahara K, Murayama H, Wakabayashi H, Kurihara T, Hashimoto K, Satoh K, Motohashi N and Sakagami H: Inhibition of LPS-stimulated NO production in mouse macrophage-like cells by benzocycloheptoxazines. Anticancer Res 28: 2657-2662, 2008.
20. Suga A, Narita T, Zhou L, Sakagami H, Satoh K and Wakabayashi H: Inhibition of NO production in LPS-stimulated mouse macrophage-like cells by benzo[b]cyclohept[e][1,4]oxazine and 2-aminotropone derivatives. In Vivo 23: 691-698, 2009.
21. Ohshima N, Akatsu Y, Yamagishi Y, Nishishiro M, Wakabayashi H, Kurihara T, Satoh K, Motohashi N and Sakagami H: Inhibition of NO production in LPS-stimulated mouse macrophage-like cells by trihaloacetylazulenes. Anticancer Res 26: 2921-2928, 2006.
22. Calabrese EJ: Paradigm lost, paradigm found: The re-emergence of hormesis as a fundamental dose-response model in the toxicological sciences. Environ Pollut 138: 379-412, 2005.
23. Cook RC and Calabrese EJ: The importance of hormesis to public health. Environ Health Perspect 114: 1631-1635, 2006.
24. Chu Q, Kobayashi M, Hashimoto K, Satoh K, Kanamoto T, Terakubo S, Nakashima H, Wang Q and Sakagami H: Antitumor potential of three herbal extracts against human oral squamous cell lines. Anticancer Res 29: 3211-3220, 2009.
25. Satoh R, Kishino K, Morshed SRM, Takayama F, Otsuki S, Suzuki F, Hashimoto K, Kikuchi H, Nishikawa H, Yasui T and Sakagami H: Changes in fluoride sensitivity during in vitro senescence of human normal oral cells. Anticancer Res 25: 2085-2090, 2005. (Pubitemid 40904608)
26. Wakabayashi H, Narita T, Suga A and Sakagami H: Hormetic response of cultured normal and tumor cells to 2-aminotropone derivatives. In Vivo 24: 39-44, 2010.
27. Kantoh K, Ono M, Nakamura Y, Nakamura Y, Hashimoto K, Sakagami H and Wakabayashi H: Hormetic and anti-radiation effects of tropolone-related compounds. In Vivo 24: 843-851, 2010.
28. Thet MM, Yokote Y, Chu Q, Wang Q-T, Kishino K, Tamura N, Shimada J, Amano O, Kanda Y, Kunii S, Takekawa F, Hatano H, Shimada C, Hasegawa H and Sakagami H: Non-apoptotic cell death induced by nutritional starvation in J774.1 mouse macrophage-like cell line. Anticancer Res 29: 5083-5088, 2009.
29. Yanagisawa-Shiota F, Sakagami H, Kuribayashi N, Iida M, Sakagami T and Takeda M: Endonuclease activity and induction of DNA fragmentation in human myelogenous leukemic cell lines. Anticancer Res 15: 259-266, 1995.
30. Chu Q, Amano O, Kanda Y, Kunii S, Wang Q and Sakagami H: Tumor-specific cytotoxicity and type of cell death induced by gefitinib in oral squamous cell carcinoma cell lines. Anticancer Res 29: 5023-5031, 2009.
31. 2 laser irradiation on hormesis induction in cultured oral cells. In Vivo 25: 93-98, 2011.
32. Erb P, Ji J, Kump E, Mielgo and Werni M: Apoptosis and pathogenesis of melanoma and nonmelanoma skin cancer. Adv Exp Med Biol 624: 283-295, 2008.
33. Nakanishi M, Niida H, Murakami H and Shimada M: DNA damage responses in skin biology-implications in tumor prevention and aging acceleration. J Dermatol Sci 56: 76-81, 2009.